| Net Cash Provided by (Used in) Operating Activities |
-193K |
USD |
+83.7% |
Q1 2023 |
Q1 2023 |
| Net Cash Provided by (Used in) Financing Activities |
240K |
USD |
-70.4% |
Q1 2023 |
Q1 2023 |
| Common Stock, Shares Authorized |
6B |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
1.6B |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
593 |
USD |
|
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Valuation Allowance |
6.65M |
USD |
+9.71% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Gross |
6.65M |
USD |
+9.71% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
31.7M |
USD |
+9.71% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
9.67M |
USD |
0% |
Q4 2024 |
FY 2024 |
| Interest Expense |
2.42M |
USD |
-32.7% |
Q4 2023 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |